GAAD score

DIAGNOSTIC_TEST3 trials

Sponsors

Erasmus Medical Center, Mahidol University, National Taiwan University Hospital

Conditions

Cancer, HepatocellularCirrhosisHBV InfectionHepatecellular CarcinomaHepatocellular Carcinoma (HCC)Type 2 Diabetes (T2DM)

Unknown Phase

To Quantify the Impact of Addition of the GAAD Score to Imaging in Patients with Chronic Liver Disease Eligible for HCC Surveillance.

RecruitingNCT06601231

Erasmus Medical CenterCancer, Hepatocellular

Start: 2024-03-18End: 2027-07-31Target: 1000Updated: 2024-09-19

STOP HCC-GAAD-APAC-Thailand

Enrolling by invitationNCT07319299

Mahidol UniversityCirrhosis, HBV Infection, Hepatecellular Carcinoma

Start: 2025-02-02End: 2027-12-31Target: 2100Updated: 2026-01-06

HCC Risk and Monitoring in Patients With Type 2 Diabetes

Not yet recruitingNCT07675187

National Taiwan University HospitalHepatocellular Carcinoma (HCC), Type 2 Diabetes (T2DM)

Start: 2026-07-01End: 2030-12-31Target: 2400Updated: 2026-07-07